InvestSMART

Nyrada Inc (ASX:NYR)

ALERT: Price-sensitive ASX Announcement for NYR
Current share price for NYR : $0.540 -0.015 (-2.70%)+
Announcement
Release
19 May 2026 4:54PM
Price at Release
$0.555
Full Release
download
Summary
Nyrada Inc., a clinical-stage biotechnology company, has requested a trading halt on the Australian Securities Exchange pending a major announcement about a preclinical oncology study. This trading halt is necessary for managing the company's continuous disclosure obligations. It will remain in effect until the announcement is released or the commencement of trading on 21 May 2026. The company's strategy is focused on innovative small-molecule therapies targeting TRPC ion channels.
Key Points
  • Nyrada Inc. requested a trading halt on the Australian Securities Exchange.
  • The halt is pending a material announcement related to a preclinical oncology study.
  • The trading halt is in accordance with ASX Listing Rule 17.1.
  • Nyrada expects to make a market announcement regarding this study.
  • The trading halt will remain until the earlier of the announcement release or the start of trading on 21 May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.